Aripiprazole and Fluid retention - a phase IV clinical study of FDA data

Summary:

Fluid retention is reported as a side effect among people who take Aripiprazole (aripiprazole), especially for people who are female, 40-49 old, also take Gabapentin, and have Stress and anxiety.

The phase IV clinical study analyzes which people have Fluid retention when taking Aripiprazole. It is created by eHealthMe based on reports of 38,853 people who have side effects when taking Aripiprazole from the FDA, and is updated regularly.

What is Aripiprazole?

Aripiprazole has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 39,143 Aripiprazole users. Check the latest studies of Aripiprazole.

What is Fluid retention?

Fluid retention (an abnormal accumulation of fluid in the blood) is found to be associated with 1,702 drugs and 2,444 conditions by eHealthMe. Check the latest studies of Fluid retention.

On Jul, 20, 2026

38,853 people reported to have side effects when taking Aripiprazole.
Among them, 35 people (0.09%) have Fluid retention.

Could Aripiprazole cause Fluid retention?

Among these 35 people:

What is the gender of people who have Fluid retention when taking Aripiprazole? *

female: 73.53 %
male: 26.47 %

What is the age of people who have Fluid retention when taking Aripiprazole? *

What are other drugs people take besides Aripiprazole? *

What are other side effects people have besides Fluid retention? *

Weight Decreased: 15 people, 42.86%
Headache (pain in head): 14 people, 40.00%
Nausea And Vomiting: 11 people, 31.43%
Nausea (feeling of having an urge to vomit): 9 people, 25.71%
Abdominal Discomfort: 9 people, 25.71%
Stress And Anxiety: 8 people, 22.86%
Dyspnea (difficult or laboured breathing): 8 people, 22.86%
Fatigue (feeling of tiredness): 8 people, 22.86%
Rashes (redness): 8 people, 22.86%
Aggression: 7 people, 20.00%

What are the existing conditions these people have? *

Stress And Anxiety: 9 people, 25.71%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 8 people, 22.86%
Psychotic Disorder: 6 people, 17.14%
Movement Disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness): 6 people, 17.14%
Immunodeficiency Common Variable: 5 people, 14.29%
High Blood Cholesterol: 3 people, 8.57%
Pain: 2 people, 5.71%
High Blood Pressure: 2 people, 5.71%
Chest Pain: 2 people, 5.71%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 2 people, 5.71%

* Approximation only. Some reports may have incomplete information.

Do you take Aripiprazole and have Fluid retention?

- Check whether Fluid retention is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Aripiprazole:

Aripiprazole (39,143 reports)

Fluid retention treatments and more:

Fluid retention (79,660 reports)

Browse all side effects of Aripiprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Fluid retention:

Fluid retention (1,702 drugs)

Browse all the conditions that are associated with Fluid retention:

Fluid retention (2,444 conditions)

Related publications that referenced our studies

Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .

How the study uses the data?

The study uses data from the FDA. It is based on aripiprazole (the active ingredients of Aripiprazole) and Aripiprazole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.